You might be interested in
2024 Preview
What’s in store for 2024: Neurotech International
V-Cons
V-Con: Talking medical innovations and breakthrough treatments with ASX biotechs
Health & Biotech
Stockhead TV
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, Fraser Palamara dissects the latest announcement from biopharmaceutical developer Neurotech (ASX:NTI) and its research into paediatric neurological disorders.
Tune in to get the latest.
While Neurotech International is a Stockhead advertiser, it did not sponsor this content.